Cited by 132Dermatologic Treatments and ResearchHair Growth and DisordersSympathectomy and Hyperhidrosis Treatments

A randomized bilateral vehicle-controlled study of eflornithine cream combined with laser treatment versus laser treatment alone for facial hirsutism in women

Hamzavi, Iltefat, Tan, Eileen, Shapiro, Jerry, Lui, Harvey·2007·Journal of the American Academy of Dermatology

Abstract

Background and objective Although there are a multitude of therapeutic modalities for removing unwanted facial hair in women, there is very little information on using the newer medical treatment approaches in combination. This study was designed to determine whether topical eflornithine can enhance the efficacy of laser hair removal. Design This was a randomized, double-blind, placebo-controlled, right-left comparison study of eflornithine cream combined with laser treatment versus laser alone for treating unwanted hair on the upper lip in women. All subjects underwent treatment to the entire upper lip with a long pulse alexandrite laser (10-40 ms pulse duration) at fluences of 7 to 40 J/cm(2). Laser treatments were performed every 4 weeks for up to 6 sessions. Each patient also applied either eflornithine or placebo cream twice daily to each side of the upper lip in a double-blinded manner. Subjects were evaluated for safety by recording adverse events and for efficacy via (1) investigator global scoring, (2) patient self assessment, and (3) hair count analysis. Results Both treatment modalities were well tolerated by the 31 evaluable patients. All 3 outcome measures showed significantly better results in favor of eflornithine plus laser versus laser treatment alone. At the end of the study, complete or almost complete hair removal was achieved in 29 of 31 (93.5%) of the eflornithine-laser-treated sites versus 21 of 31 (67.9%) for the placebo cream-laser-treated sites (P = .021, McNemar test). Statistically significant differences in favor of eflornithine were likewise demonstrated at the final assessment through blinded patient grading (13/31 patients [41.9%] thought that the eflornithine was superior to placebo, P = .029, Poisson regression) and hair count analysis (P < .01, paired t test). Limitations This is a single-center study that did not determine whether the differences noted above last beyond 6 months. Conclusions On the basis of both investigator and patient assessments and hair count analysis, we have demonstrated that the addition of eflornithine to laser hair removal results in a more rapid and complete reduction of unwanted facial hair in women when the combination is used for up to 6 months.

Integrity signals

Registry

Crossref · 10.1016/j.jaad.2006.09.025

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

The citation lists haven’t been fetched yet

References 7 · Cited by 132

Authors
Hamzavi, I., Tan, E., Shapiro, J., & Lui, H.
Affiliations
University of British Columbia (CA)
Corresponding author
Lui, Harvey
Venue
Journal of the American Academy of Dermatology
Publisher
Elsevier BV
Published
2007-07
Volume
57
Issue
1
Pages
54-59
ISSN
0190-9622 (ISSN-L)
OpenAlex
W1970753372
Cited by
132
References
7
Citations by year
2026: 6 · 2025: 3 · 2024: 6 · 2023: 5 · 2022: 3 · 2021: 4 · 2020: 4 · 2019: 3 · 2018: 5 · 2017: 7 · 2016: 6 · 2015: 9 · 2014: 5 · 2013: 7 · 2012: 11
FWCI
13.02
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of the American Academy of Dermatology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Dermatology › Dermatologic Treatments and Research
  • Health Sciences › Medicine › Urology › Hair Growth and Disorders
  • Health Sciences › Medicine › Physiology › Sympathectomy and Hyperhidrosis Treatments
Keywords
difluoromethylornithine, laser hair removal, combination therapy
MeSH terms
Adult, Aged, Eflornithine, Combined Modality Therapy, Double-Blind Method, Female, Hair Removal, Hirsutism, Humans, Lip, Middle Aged, Treatment Outcome, Low-Level Light Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review